$2.26
11.33% day before yesterday
Nasdaq, Dec 27, 10:18 pm CET
ISIN
US65443P1021
Symbol
MASS

908 Devices Inc Stock price

$2.26
-0.36 13.74% 1M
-2.89 56.12% 6M
-8.96 79.86% YTD
-7.83 77.60% 1Y
-22.60 90.91% 3Y
-17.74 88.70% 5Y
-17.74 88.70% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.23 11.33%
ISIN
US65443P1021
Symbol
MASS
Sector

Key metrics

Market capitalization $78.70m
Enterprise Value $14.19m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.26
P/S ratio (TTM) P/S ratio 1.43
P/B ratio (TTM) P/B ratio 0.60
Revenue growth (TTM) Revenue growth 16.08%
Revenue (TTM) Revenue $55.16m
EBIT (operating result TTM) EBIT $-32.28m
Free Cash Flow (TTM) Free Cash Flow $-30.68m
Cash position $71.69m
EPS (TTM) EPS $-1.78
P/E forward negative
P/S forward 1.38
EV/Sales forward 0.25
Short interest 6.31%
Show more

Is 908 Devices Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

908 Devices Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a 908 Devices Inc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a 908 Devices Inc forecast:

Buy
80%
Hold
20%

Financial data from 908 Devices Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
55 55
16% 16%
100%
- Direct Costs 29 29
14% 14%
53%
26 26
18% 18%
47%
- Selling and Administrative Expenses 31 31
26% 26%
57%
- Research and Development Expense 23 23
17% 17%
41%
-28 -28
29% 29%
-52%
- Depreciation and Amortization 3.84 3.84
50% 50%
7%
EBIT (Operating Income) EBIT -32 -32
25% 25%
-59%
Net Profit -60 -60
55% 55%
-109%

In millions USD.

Don't miss a Thing! We will send you all news about 908 Devices Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

908 Devices Inc Stock News

Neutral
Business Wire
10 days ago
BOSTON--(BUSINESS WIRE)-- #automation--Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge's bioreactors with 908 Devices' MAVEN for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure critical process parameters in bioreactors, offering continuous, real-time analysis without the ne...
Neutral
Seeking Alpha
about 2 months ago
908 Devices Inc. (NASDAQ:MASS ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Kelly Gura - Gilmartin Group Kevin Knopp - Chief Executive Officer and Co-Founder Joe Griffith - Chief Financial Officer Conference Call Participants Puneet Souda - Leerink Partners Sam Martin - William Blair Hannah Hefley - Stepehens Chad Wiatrowski - TD Cowen Operator Hello, and ...
Neutral
Business Wire
about 2 months ago
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended September 30, 2024. “While we are pleased that our revenue increased year-over-year due to our newly acquired products, our third quarter results fell short of our expectations due to challenges from the d...
More 908 Devices Inc News

Company Profile

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

Head office United States
CEO Kevin Knopp
Employees 230
Founded 2012
Website www.908devices.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today